National / Science & Health | FOCUS Jul 4, 2023
Expectations grow for Alzheimer's drug in Japan, but hurdles remain
by Tomoko Otake
Lecanemab could be approved in the country as early as fall, but more specialist doctors and a patient screening system would be needed for widespread use.
